Avia Pharma signs strategic agreement with Omega Pharma

Avia Pharma signs strategic agreement with Omega Pharma

Avia Pharma has entered into an in-licensing agreement with Omega Pharma for the following products; Duroferon, Ferro Duretter, Minifom, D-vitamin Olja ACO, D-vitamin Vatten ACO, Dunmedic Vitamin D-olja and Nix.
Under the agreement Avia Pharma will handle all commercial aspects of the products.

”Omega Pharma wanted a strong and competent partner to work with this product portfolio and we have found precisely that in Avia Pharma. This commercial collaboration also allows Omega Pharma to focus on our core strategic initiatives” says Adrian Innergård, Commercial Director of Omega Pharma

“We are very happy that Omega Pharma have put their trust in Avia Pharma and we will make sure that this co-operation will be a success for both parties” says Jacob Calmvik, CEO of Avia Pharma

”This is an important first step in Avia Pharma’s development and it will be followed both by additional in-licensing agreements as well as acquisitions of product portfolios” says Jostein Lönberg, Executive Chairman of Avia Pharma

For more information please contact:

Jacob Calmvik, CEO of Avia Pharma
Jacob.calmvik@aviapharma.se
+46 703 70 71 69


Avia Pharma is a fast growing and innovative company with a robust and sustainable business model. Our goal is to become the market leader in selected therapeutic areas with prescription and OTC products

Avia Pharma
Svärdvägen 3B
182 33 Danderyd
www.aviapharma.se